Latest developments in causes and treatments




More Studies Show Positive Impacts From GLP-1 Agonist Drugs

A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.

Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders

Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.

People Who Stop Taking GLP-1 Drugs Such As Ozempic and Wegovy Rapidly Gain Back Weight

New reporting documents the weight gain when people stop taking GLP-1 drugs such as Ozempic and Wegovy.